Erratum: Lysyl oxidase promotes anaplastic thyroid carcinoma cell proliferation and metastasis mediated via BMP1
Erratum to: Gland Surg 2022;11:245-57.
In the January 2022 Issue of Gland Surgery (Vol 11, No 1), the article titled “Lysyl oxidase promotes anaplastic thyroid carcinoma cell proliferation and metastasis mediated via BMP1” (Liu et al. 2022) (1) was published with some errors in Figure 4 and Figure 5. The images for Figure 4H (0 hour BAPN) and the Figure 4F (0 hour Control) are the same. The reason is that the Figure 4H (0 hour BAPN)’s image was mistakenly duplicated as that of the Figure 4F (0 hour Control). Additionally, due to errors that occurred during the preparation and assembly of the figures, the images for Figure 5E (si-BMP1) were also misused in Figure 4G (BAPN).
The corrected Figure 4 is shown as below (the figure legend remains intact):
The corrected Figure 5 is shown as below (the figure legend remains intact):
The authors sincerely apologize for the error and any inconvenience it may have caused. The correction does not compromise the validity of the conclusions and the overall content of the article.
Click here to view the updated version of the article.
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons AttributionNonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-ncnd/4.0/.
References
- Liu Y, Zhang Y, Tan Z, et al. Lysyl oxidase promotes anaplastic thyroid carcinoma cell proliferation and metastasis mediated via BMP1. Gland Surg 2022;11:245-57. [Crossref] [PubMed]
